Advanced search
Publication Cover
Expert Review of Molecular Diagnostics Volume 11, 2011 - Issue 8
Submit an article Journal homepage
91
Views
14
CrossRef citations to date
0
Altmetric
Editorial

Promises and challenges in developing miRNA as a molecular diagnostic tool for lung cancer

William CS Cho Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13/F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong. [email protected]
Pages 763-766 | Published online: 09 Jan 2014

References

  • Jemal A, Bray F, Center MM, Felay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin.61(2), 69–90 (2011).
  • Cho WC. MicroRNAs as therapeutic targets for lung cancer. Expert Opin. Ther. Targets14(10), 1005–1008 (2010).
  • Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int. J. Biochem. Cell Biol.42(8), 1273–1281 (2010).
  • Cho WC. Molecular diagnostics for monitoring and predicting therapeutic effect in cancer. Expert Rev. Mol. Diagn.11(1), 9–12 (2011).
  • Cho WC. Recent progress in genetic variants associated with cancer and their implications in diagnostics development. Expert Rev. Mol. Diagn.10(6), 699–703 (2010).
  • Chu H, Wang M, Shi D et al.Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case–control studies. PLoS One6(3), e18108 (2011).
  • Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ. MiR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J. Thorac. Oncol.6(3), 482–488 (2011).
  • Chen X, Hu Z, Wang W et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int. J. Cancer DOI: 10.1002/ijc.26177 (2011) (Epub ahead of print).
  • Keller A, Leidinger P, Gislefoss R et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol.8(3), 506–516 (2011).
  • Heegaard NH, Schetter AJ, Welsh JA, Yoneda M, Bowman ED, Harris CC. Circulating microRNA expression profiles in early stage non-small cell lung cancer. Int. J. Cancer DOI:10.1002/ijc.26153 (2011) (Epub ahead of print).
  • Roth C, Kasimir-Bauer S, Pantel K, Schwarzenbach H. Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer. Mol. Oncol.5(3), 281–291 (2011).
  • Bianchi F, Nicassio F, Marzi M et al. A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer. EMBO Mol. Med.3(8), 495–503 (2011).
  • Boeri M, Verri C, Conte D et al. MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc. Natl Acad. Sci. USA108(9), 3713–3718 (2011).
  • Hu Z, Chen X, Zhao Y et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J. Clin. Oncol.28(10), 1721–1726 (2010).
  • Watanabe K, Emoto N, Hamano E et al. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer. Int. J. Cancer DOI: 10.1002/ijc.26254 (2011) (Epub ahead of print).
  • Arora S, Ranade AR, Tran NL et al.MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration. Int. J. Cancer129(11), 2621–2631 (2011).
  • Saito M, Schetter AJ, Mollerup S et al. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin. Cancer Res.17(7), 1875–1882 (2011).
  • Donnem T, Lonvik K, Eklo K et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer117(14), 3193–3200 (2011).
  • Cho WC, Chow AS, Au JS. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol.8(1), 125–131 (2011).
  • Cho WC. MicroRNAs in cancer – from research to therapy. Biochim. Biophys. Acta1805(2), 209–217 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.